Biomax SRL
Biomax reported total assets of 703,093 € at the end of the 2025 financial year (annual accounts filed with the NBB on 05 Jun 2026).
The score of Biomax shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +58 % Total assets +55 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Biomax's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 94,469 € | ||||
| Equity | 679,267 € | ||||
| Cash | 205,870 € | ||||
| EBITDA | 128,057 € | ||||
| Total assets | 703,093 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 05 Jun 2026
- Year ended 31 Dec 2024filed on 06 Jun 2025
- Year ended 31 Dec 2023filed on 10 Jun 2024
- Year ended 31 Dec 2022filed on 16 Jun 2023
- Year ended 31 Dec 2021filed on 07 Jun 2022
Biomax's financial analysis
- Solvency96.6%sector median: 65.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Biomax
Biomax's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0691.941.184
- VAT number
- BE0691941184
- Peppol
- Registered · 0208:0691941184 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 12 Mar 2018
- Registered office
- 6900 Marche-en-Famenne
- Latest accounts
- 2025 · filed on 05 Jun 2026
- Activity
- Medical specialists activities (NACE 86220)
Biomax (SRL) has been based in Marche-en-Famenne since 2018, active in: medical specialists activities. For 2025, it reports a net profit of 94,469 € and equity of 679,267 €; its revenue is not published. Its solvency stands at 96.6%, above the median of its sector (65.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Biomax
Companies in the same business, of comparable size and area, outside its group.
- Limcoal Maaseik · balance sheet 701,467 €
- Brebisimmo Manufacture of other non-metallic mineral products n.e.c. Watermael-Boitsfort · balance sheet 702,768 €
- Femobel Bierbeek · balance sheet 702,271 €
- Groep G.I.Z. Manufacture of basic pharmaceutical products Oudsbergen · balance sheet 702,087 €
- Marbim Keerbergen · balance sheet 703,027 €
- Neomezza Ninove · balance sheet 703,889 €
- Cabinet Médical du Docteur DUPONT Herstal · balance sheet 702,201 €
Frequently asked questions about Biomax
What is the revenue of Biomax?
Biomax files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Biomax?
In Belgium, the VAT number is the company number prefixed with BE: BE0691941184 for Biomax, if the company is VAT-registered. Its company number (CBE) is 0691.941.184.
Where is the registered office of Biomax?
According to the CBE register, the registered office of Biomax is in 6900 Marche-en-Famenne.
What is the equity of Biomax?
At the close of the 2025 financial year, the equity of Biomax amounts to 679,267 €, a solvency of 96.6% of total assets.
Who manages Biomax?
The register lists 2 active mandates at Biomax. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Biomax
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →